Bavdegalutamide : PROTACs in the Management of Prostate Cancer
Enpp-1-IN-1 : Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma
BLU-945 : Binding Thermodynamics of Fourth-Generation EGFR Inhibitors Revealed by Absolute Binding Free Energy Calculations
MDL-800 : SIRT6 pharmacological inhibition delays skin cancer progression in the squamous cell carcinoma
EIDD-1931 : Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo
ML390 : Current challenges in the treatment of gliomas: The molecular era
Prexasertib: Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
Orelabrutinib : Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases
SKL2001: Role of the β-Catenin/REG Iα Axis in the Proliferation of Sessile Serrated Adenoma/Polyps Associated with Fusobacterium nucleatum